OZYMF logo

Orphazyme A/S

OZYMF

$0.09

Key details

CEO

Kim Stratton

Employees

19

Headquarters

Copenhagen N, Denmark

Sector

Manufacturing

Industry

Pharmaceutical Preparation Manufacturing

About Orphazyme A/S

orphazyme is a danish biotech-company focused on the development of novel therapies for lysosomal storage diseases. orphazyme was founded in june 2009 by thomas kirkegaard jensen (phd, ceo), martin rahbek kornum (patent attorney, ch. of board), anders hinsby (partner, bankinvest biomedical venture) & marja jäättelä (prof., head of dep. of apoptosis) via a pre-seed grant from the novo nordisk foundation.

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday pricing and company data provided by IEX.
Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG